| 
				 PNGase F  | 
		||||||
| 
				 
  | 
			
				 
  | 
			
				 Cat.No.:  | 
			
				 CYT-P21163  | 
			
				 
  | 
			
				 
  | 
			
				 
  | 
		
| 
				 Background  | 
		||||||
| 
				 PNGase F  | 
		||||||
| 
				 Measured by its ability to deglycosylate ribonuclease B under denatured conditions. >50% ribonuclease B (10 ¦Ìg) is deglycosylated by 2.4 ng rFmPNGase F within 60 minutes, as measured under the described conditions.Peptide -N-Glycosidase F, also known as PNGase F, is an amidase that cleaves between the innermost GlcNAc and asparagine residues of high mannose, hybrid, and complex oligosaccharides from N-linked glycoproteins.  | 
		||||||
| 
				 Information  | 
		||||||
| 
				 Source  | 
			
				 Escherichia coli.  | 
		|||||
| 
				 Molecular Weight  | 
			
				 Approximately 35KD.  | 
		|||||
| 
				 AA Sequence  | 
			
				 APADNTVNIKTFDKVKNAFGDGLSQSAEGTFTFPADVTTVKTIKMFIKNECPNKTCDEWDRY ANVYVKNKTTGEWYEIGRFITPYWVGTEKLPRGLEIDVTDFKSLLSGNTELKIYTETWLAKG REYSVDFDIVYGTPDYKYSAVVPVIQYNKSSIDGVPYGKAHTLGLKKNIQLPTNTEKAYLRTT ISGWGHAKPYDAGSRGCAEWCFRTHTIAINNANTFQHQLGALGCSANPINNQSPGNWAPDR AGWCPGMAVPTRIDVLNNSLTGSTFSYEYKFQSWTNNGTNGDAFYAISSFVIAKSNTPISAPV VTN  | 
		|||||
| 
				 Unit Definition Assay  | 
			
				 10 ¦Ìg of RNase B are denatured with 1X Glycoprotein Denaturing Buffer (0.5% SDS, 40 mM DTT) at 100¡ãC for 10 minutes. After the addition of NP-40 and GlycoBuffer 2, two-fold dilutions of PNGase F are added and the reaction mix is incubated for 1 hour at 37¡ãC. Separation of reaction products are visualized by SDS-PAGE.  | 
		|||||
| 
				 Physical Appearance  | 
			
				 Sterile Filtered Clear Solution..  | 
		|||||
| 
				 Formulation  | 
			
				 Supplied as a 0.2 ¦Ìm filtered solution of PBS, pH 7.4, 10% Glycerol.  | 
		|||||
| 
				 Endotoxin  | 
			
				 Less than 0.1 EU/mg of rHuEGF as determined by LAL method.  | 
		|||||
| 
				 Reconstitution  | 
			
				 We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ¡Ü -20¡æ. Further dilutions should be made in appropriate buffered solutions.  | 
		|||||
| 
				 Purity  | 
			
				 > 95 % by SDS-PAGE and HPLC analyses.  | 
		|||||
| 
				 Stability & Storage  | 
			
				 It is recommended to freeze aliquots at -80¡ãC for extended storage. Avoid repeated freeze-thaw cycles.  | 
		|||||
| 
				 Stored at -80¡æ for 1 year.  | 
		||||||
| 
				 2 weeks, 2 to 8¡æunder sterile conditions after reconstitution.  | 
		||||||
| 
				 It is stable at -20¡æ for 3 months after opening.  | 
		||||||
| 
				 Usage Information  | 
			
				 
  | 
			
				 
  | 
			
				 
  | 
			
				 
  | 
			
				 
  | 
			
				 
  | 
		
| 
				 This product is offered by BioCytoSci only for Scientific Research & Laboratory USE. NOT FOR OTHER USE.  | 
		||||||
| 
				 Order Information  | 
			
				 
  | 
			
				 
  | 
			
				 
  | 
			
				 
  | 
			
				 
					  | 
		|
| 
				 Cata.No.  | 
			
				 Quantity  | 
			
				 Price($)  | 
			
				 Price($)  | 
			
				 Availability  | 
		||
| 
				 CYT-P21163  | 
			
				 5,000 units  | 
			
				 $156.00  | 
			
				 €171.60  | 
			
				 In stock  | 
		||
| 
				 CYT-P21163  | 
			
				 15,000 units  | 
			
				 $296.00  | 
			
				 €325.60  | 
			
				 In stock  | 
		||
| 
				 CYT-P21163  | 
			
				 75,000 units  | 
			
				 $1,300.00  | 
			
				 €1,430.00  | 
			
				 In stock  | 
		||
| 
				 Free Delivery on orders over $200.00.  | 
		||||||
| 
				 We Devoted Ourselves To The Development Of Biomedical Research Reagent.  | 
		||||||


